Spain· ES:1201493001
LIBMELDY 2-10 X 10^6 CELULAS/ML DISPERSION PARA PERFUSION
A medicinal product containing atidarsagén autotemcel, registered in Spain by Orchard Therapeutics (Netherlands) B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- atidarsagén autotemcel
- Manufacturer
- Orchard Therapeutics (Netherlands) B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atidarsagén autotemcel in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLibmeldy 2 10*6 cells/ml - 10 10*6 cells/mlOrchard Therapeutics (Netherlands)
- IcelandLibmeldyOrchard Therapeutics (Netherlands) B.V.
- United StatesLENMELDYOrchard Therapeutics (Europe) Ltd
- FranceLIBMELDY 2-10 x 1 000 000 cellules / ml, dispersion pour perfusionORCHARD THERAPEUTICS (NETHERLANDS) (PAYS-BAS)
- United KingdomLibmeldy 2million-10million cells/ml dispersion for infusion bagsOrchard Therapeutics (Europe) Ltd
- IrelandLibmeldy 2-10 x 106 cells/mL dispersion for infusionOrchard Therapeutics (Netherlands) B.V.
- SwedenLibmeldy 2 - 10 miljoner celler/ml Infusionsvätska, dispersionOrchard Therapeutics (Netherlands) BV
- NetherlandsLibmeldy 2-10 x 10^6 cellen/ml dispersie voor infusieOrchard Therapeutics (Netherlands) B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Libmeldy, Strimvelis
- Liechtenstein · Libmeldy, Strimvelis
- Norway · Libmeldy, Strimvelis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/412a1ae5-2627-40d0-9d6d-43f31b2668d7 GET /v1/drugs/412a1ae5-2627-40d0-9d6d-43f31b2668d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1634636011000}",
"nregistro": "1201493001",
"substance": "atidarsagén autotemcel"
}See everything about atidarsagén autotemcel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.